Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-24-016240

Chief Scientific Officer sold 21,078 shares at an average $57.33 ($1,208,418)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Reich Kristian · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-20 Sale : show line 1 in the form 10b5-1 −10,000 $57.45 $574,500 2,987,483 I
2024-02-20 Sale : show line 2 in the form 10b5-1 −10,000 $57.43 $574,300 100,071 D
2024-02-21 Sale : show line 3 in the form 10b5-1 −509 $55.31 $28,153 2,986,974 I
2024-02-21 Sale : show line 4 in the form 10b5-1 −569 $55.30 $31,466 99,502 D
Open-market sales · 21,078 sh · avg $57.33 · $1,208,418
Loading xslF345X05/ownership.xml…